[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Howell et al., 1970 - Google Patents

Changes in the central nervous system of lambs following the administration of sodium diethyldithiocarbamate

Howell et al., 1970

Document ID
10471866011312459714
Author
Howell J
Ishmael J
Ewbank R
Blakemore W
Publication year
Publication venue
Acta Neuropathologica

External Links

Snippet

Two days old and 1 month old lambs were given repeated intraperitoneal injections of sodium diethyldithiocarbamate (NDDC) in phosphate buffer or phosphate buffer alone. All but one NDDC treated lamb died before 16 weeks when this animal and the 4 controls were …
Continue reading at link.springer.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epihephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/30—Macromolecular compounds
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Chang Neurotoxic effects of mercury—a review
Cavanagh et al. The effects of methyl-mercury-dicyandiamide on the peripheral nerves and spinal cord of rats
Matulionis Ultrastructural study of mouse olfactory epithelium following destruction by ZnSO4 and its subsequent regeneration
DE69922633T2 (en) Pheromone-containing composition for reducing stress, anxiety and contentiousness in pigs
Cragg et al. Natural loss of Purkinje cells during development and increased loss with alcohol
DE2618129A1 (en) SOLID SUBcutaneously IMPLANTABLE PILL CONTAINING A BIOLOGICALLY EFFECTIVE AMOUNT OF 2 ALPHA-METHYLANDROSTAN-17BETA- 0L-3-ON-17-PROPIONATE, METHOD OF PRODUCTION AND USE
Howell et al. Changes in the central nervous system of lambs following the administration of sodium diethyldithiocarbamate
Chang et al. Ultrastructural study of the latent effects of methyl mercury on the nervous system after prenatal exposure
Cameron et al. Observations on the histological effects of sub-lethal doses of cadmium chloride in the rabbit: I. The effect on the testis
DE60224202T2 (en) INCREASED SOLUBILITY OF FLAVANOLIGNAN PREPARATIONS
DE3526545A1 (en) NEW PHARMACEUTICAL APPLICATION OF (NVA) (UP ARROW) 2 (UP ARROW) - AND DIHYDRO- (VAL) (UP ARROW) 2 (UP ARROW) -CYCLOSPORINE
Kelly et al. Spongy degeneration of the central nervous system in kittens
Schmidt et al. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats
DE69533311T2 (en) METHOD FOR TREATING AUTOIMMUNE DISEASES BY TYPE-1 INTERFERONS
Montgomery et al. Hereditary striatonigral and cerebello-olivary degeneration of the Kerry blue terrier. I. Gross and light microscopic central nervous system lesions
DE69832165T2 (en) HGF FOR THE TREATMENT OF ACUTE KIDNEY FAILURE
LUBITZ et al. Complete cerebral ischaemia in the rat: An ultrastructural and stereological analysis of the distal stratum radiatum in the hippocampal CA‐1 region
CH639560A5 (en) Pharmaceutical preparation having a prolonged uniform active compound release
Liu et al. Intrathalamic injections of γ-hydroxybutyric acid increase genetic absence seizures in rats
Said et al. Proliferation of Schwann cells in tellurium-induced demyelination in young rats: a radioautographic and teased nerve fiber study
DE2835292C2 (en) Process for the production of defibrinized and freeze-dried placental cells
Doncon et al. Plasma and liver concentrations of aP‐tocopherol in weaner sheep after vitamin E supplementation
Carlton et al. Tellurium toxicosis in Pekin ducks
Buck et al. Copper toxicity in sheep
Peterson et al. Brain damage by extracts of parasitised annual ryegrass (Lolium rigidum) in nursling rats